AbbVie (ABBV) Earnings Date, Estimates & Call Transcripts → Who are Nvidia’s Silent Partners? (From Weiss Ratings) (Ad) Free ABBV Stock Alerts $171.52 +2.53 (+1.50%) (As of 06/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateJul. 25EstimatedActual EPS (May. 3) $2.31 Beat By $0.05 Consensus EPS (May. 3) $2.26 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get AbbVie Earnings AlertsEnter your email address below to receive the latest news and earnings results for ABBV and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueABBV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABBV Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” AbbVie Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244$2.21$10.93$4.402.180 - 2.220Q2 20244$2.98$12.20$5.323.050 - 3.090Q3 20244$2.86$13.31$5.49 Q4 20244$3.02$14.29$5.85 FY 202416$11.07$50.73$21.05 Q1 20251$2.73$2.73$2.73 Q2 20251$2.98$2.98$2.98 Q3 20251$3.04$3.04$3.04 Q4 20251$3.30$3.30$3.30 FY 20254$12.05$12.05$12.05 Q1 20261$2.96$2.96$2.96 ABBV Earnings Date and InformationAbbVie last announced its quarterly earnings data on May 3rd, 2024. The reported $2.31 earnings per share for the quarter, topping analysts' consensus estimates of $2.26 by $0.05. The business had revenue of $12.31 billion for the quarter, compared to analyst estimates of $11.93 billion. Its revenue was up .7% compared to the same quarter last year. AbbVie has generated $3.37 earnings per share over the last year ($3.37 diluted earnings per share) and currently has a price-to-earnings ratio of 50.9. Earnings for AbbVie are expected to grow by 7.36% in the coming year, from $11.27 to $12.10 per share. AbbVie has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off prior year's report dates.Read More AbbVie Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/25/2024(Estimated)------- 5/3/2024Q1 2024$2.26$2.31+$0.05$3.85$11.93 billion$12.31 billion 2/2/2024Q4 2023$2.76$2.79+$0.03$5.12$14.02 billion$14.30 billion 10/27/2023Q3 2023$2.86$2.95+$0.09$4.90$13.72 billion$13.93 billion 7/27/2023Q2 2023$2.79$2.91+$0.12$4.68$13.52 billion$13.87 billion4/27/2023Q1 2023$2.44$2.46+$0.02$4.79$12.23 billion$12.23 billion 2/9/2023Q4 2022$3.54$3.60+$0.06$5.82$15.30 billion$15.12 billion Get the Latest News and Ratings for ABBV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbbVie and its competitors with MarketBeat's FREE daily newsletter. 10/28/2022Q3 2022$3.56$3.66+$0.10$5.11$14.95 billion$14.81 billion 7/29/2022Q2 2022$3.42$3.51+$0.09$6.51$14.64 billion$14.58 billion 4/29/2022Q1 2022$3.15$3.16+$0.01$3.81$13.61 billion$13.36 billion 2/2/2022Q4 2021$3.29$3.31+$0.02$4.36$14.96 billion$14.89 billion 10/28/2021Q3 2021$3.22$3.33+$0.11$4.88$14.30 billion$14.34 billion 7/29/2021Q2 2021$3.09$3.11+$0.02$5.80$13.64 billion$13.96 billion 4/29/2021Q1 2021$2.83$2.95+$0.12$3.91$12.84 billion$13.01 billion 2/2/2021Q4 2020$2.85$2.92+$0.07$5.83$13.70 billion$13.86 billion 10/30/2020Q3 2020$2.75$2.83+$0.08$4.37$12.71 billion$12.88 billion 7/31/2020Q2 2020$2.20$2.34+$0.14$5.14$10.14 billion$10.43 billion 5/1/2020Q1 2020$2.25$2.42+$0.17$2.82$8.31 billion$8.62 billion 2/7/2020Q4 2019$2.19$2.21+$0.02$2.54$8.68 billion$8.70 billion 11/1/2019Q3 2019$2.29$2.33+$0.04$3.40$8.37 billion$8.48 billion 7/26/2019Q2 2019$2.21$2.26+$0.05$4.03$8.09 billion$8.26 billion AbbVie Earnings - Frequently Asked Questions When is AbbVie's earnings date? AbbVie has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off last year's report dates. Learn more on ABBV's earnings history. Did AbbVie beat their earnings estimates last quarter? In the previous quarter, AbbVie (NYSE:ABBV) reported $2.31 earnings per share (EPS) to beat the analysts' consensus estimate of $2.26 by $0.05. Learn more on analysts' earnings estimate vs. ABBV's actual earnings. How can I listen to AbbVie's earnings conference call? The conference call for AbbVie's latest earnings report can be listened to online. Listen to Conference Call How can I read AbbVie's conference call transcript? The conference call transcript for AbbVie's latest earnings report can be read online. Read Transcript How can I view AbbVie's earnings report? AbbVie's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded annual revenue of $54.40 billion. How much profit does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded net income of $4.86 billion. ABBV has generated $3.37 earnings per share over the last four quarters. What is AbbVie's price-to-earnings ratio? AbbVie (NYSE:ABBV) has a trailing price-to-earnings ratio of 50.90 and a forward price-to-earnings ratio of 15.22. The price/earnings-to-growth ratio is 2.16. What is AbbVie's EPS forecast for next year? AbbVie's earnings are expected to grow from $11.27 per share to $12.10 per share in the next year, which is a 7.36% increase. More Earnings Resources from MarketBeat Related Companies: Amgen Earnings Results Gilead Sciences Earnings Results Moderna Earnings Results Seagen Earnings Results IDEXX Laboratories Earnings Results IQVIA Earnings Results BioNTech Earnings Results Illumina Earnings Results Janux Therapeutics Earnings Results Eli Lilly and Company Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: BlackBerry Stock: Strong Earnings, Profitability Challenges AheadWalgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts AheadAurora Cannabis Earnings Reveal a Turning Tide for the StockDarden Stock Up After Q4 Earnings Beat, Cautious FY25 OutlookAccenture’s Stock Earnings Reveal an AI-Powered Growth StrategySignet Jewelers Stock Poised for Rebound After Earnings DropApple Stock All-Time Highs: Can AI Outweigh Earnings Jitters? This page (NYSE:ABBV) was last updated on 6/30/2024 by MarketBeat.com Staff From Our PartnersA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredNext-Gen AI is Creating Millionaires Right NowI predict massive unemployment is coming. 800 million could lose their jobs, according to a McKinsey study,...InvestorPlace | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.